LeMaitre Vascular appoints Dorian LeBlanc as CFO; base salary $565,000, target bonus $225,000

LEMAITRE VASCULAR INC

Dorian LeBlanc appointed CFO effective March 10, 2025; previously CFO at LumiraDx (acquired by Roche).
Annual base salary $565,000; target performance bonus $225,000; annual equity award $375,000 (4-year vesting).
One-time RSU grant of $100,000 with 4-year vesting; eligible for 401(k) match, 25 vacation days.
Severance: $100,000 if termination without cause before Mar 10, 2028; after, greater of 2 weeks' salary per year or $225,000.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dorian LeBlanc

Chief Financial Officer

LMAT · LEMAITRE VASCULAR INC

Effective: 2025-03-10
Filed: February 13, 2025, 6:59 PM ET

On February 7, 2025, LeMaitre Vascular, Inc. (the “Company”) agreed to terms with Dorian LeBlanc to become the Chief Financial Officer and principal financial officer of the Company, effective on March 10, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dorian LeBlanc was appointed as Chief Financial Officer at LEMAITRE VASCULAR INC.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On February 7, 2025, LeMaitre Vascular, Inc. (the “Company”) agreed to terms with Dorian LeBlanc to become the Chief Financial Officer and principal financial officer of the Company, effective on March 10, 2025.

View on SEC.gov

LEMAITRE VASCULAR INC filing history →

Source: SEC EDGAR

accession 0001437749-25-003679

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.